美国的体外受精设备市场评估:各产品类型，各次序类型，各终端用户，各地区，机会及预测，2018～2032年

美国 IVF 设备市场预计将从 2024 年的 60.7 亿美元成长到 2032 年的 85.7 亿美元，预测期间（2025-2032 年）的复合年增长率为 4.41%。

由于先进技术和基础设施的出现，以及对高效解决方案的需求不断增加，美国 IVF 市场取得了显着增长。推动该国市场扩张的主要因素之一是由于久坐的生活方式和环境条件的变化导致很大一部分人口的生殖功能下降。如今，围绕生殖医学的禁忌正在解除，随着公众意识的提高，人们越来越愿意接受生殖医学。此外，政府还透过监管和保险支援、医疗保健基础设施投资、技术进步以及对尖端解决方案的需求不断增长等形式推动市场的成长轨迹。

例如，Fertility USA 和 Ovation Fertility 于 2023 年 4 月宣布建立合作伙伴关係，成为美国最知名的不孕症治疗组织。该联盟透过应用行业最佳实践来提高可及性、患者满意度和健康结果，寻求促进创新和发展。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 美国的体外受精设备市场预测，2018年～2032年

• 市场规模的分析与预测
  • 各金额
• 市场占有率分析与预测
  • 各产品类型
    • 设备
    • 试剂和培养基
    • 软体和服务
  • 各次序类型
    • 新鲜捐赠者的体外受精
    • 新鲜的非捐赠者体外受精
    • 冻结捐赠者体外受精
    • 冻结非捐赠者体外受精
    • 自然地週期体外受精
    • 其他
  • 各终端用户
    • 不孕治疗诊所
    • 医院
    • 调查机关及学术中心
    • 冷冻银行
  • 各地区
    • 东北部
    • 中西部
    • 西部
    • 南部
  • 市场占有率分析(前五名公司以及其他- 各金额，2024年)，各企业
• 市场地图分析，2024年
  • 各产品类型
  • 各次序类型
  • 各终端用户
  • 各地区

第5章 需求供给分析

第6章 价值链分析

第7章 波特的五力分析

第8章 大环境分析

第9章 价格分析

第10章 市场动态

• 推动市场要素
• 市场课题

第11章 市场趋势与发展

第12章 法规结构和革新

• 专利形势
• 法规当局的认证
• 革新/新兴技术

第13章 案例研究

第14章 竞争情形

• 前五名市场领导公司的竞争矩阵
• 前五名公司的SWOT分析
• 前十大市场主要企业的形势
  • Becton, Dickinson and Company
  • 公司概要
  • 主要经营团队
  • 产品和服务
  • 财务状况(如报告)
  • 主要市场焦点和地理存在感
  • 最近的趋势/合作/伙伴关係/合併和收购
  • CooperSurgical, Inc.
  • Thermo Fisher Scientific Inc.
  • Irvine Scientific Inc.
  • MilliporeSigma(Merck KGaA)
  • Vitrolife Inc.
  • Eppendorf North America, Inc.
  • Leica Biosystems, Inc.
  • Hamilton Company
  • Origio USA, Inc.

上述公司不依市场占有率排序，并且可能会根据研究工作期间获得的资讯进行更改。

第15章 策略性建议

第16章 关于调查公司·免责声明

United States in-vitro fertilization instruments market is projected to witness a CAGR of 4.41% during the forecast period 2025-2032, growing from USD 6.07 billion in 2024 to USD 8.57 billion in 2032.

The United States market for in-vitro fertilization has grown significantly because of the availability of advanced techniques and infrastructure coupled with the growing demand for efficient solutions. One of the primary factors propelling market expansions in the country is most of the population's declining reproductive health as a result of sedentary lifestyles and shifting environmental conditions. The taboo which is still associated with it is now dissolving and people are more freely availing these medical options as awareness spreads more around the country. Furthermore, the market's growth trajectory is being reinforced by the government in the form of regulatory and insurance support and the investments they make in healthcare infrastructure, advancements in technology, and the growing demand for cutting-edge solutions.

For example, U.S. Fertility & Ovation Fertility announced a partnership arrangement in April 2023 to become the most well-known fertility organization in the United States. By applying industry best practices to improve accessibility, patient satisfaction, and health outcomes, the alliance seeks to spur innovation and growth.

Technological Advancements in In-Vitro Fertilization Instruments Boosts Market Growth

Reproductive technology advancements have transformed IVF procedures in the US, increasing success rates and simplifying treatment plans. Clinics are now able to maximize embryo viability and minimize treatment cycles due to recent innovations such as AI-driven embryo selection tools, enhanced time-lapse imaging, and sophisticated cryopreservation methods such as vitrification. By increasing the likelihood of a successful pregnancy, these improvements boost professional efficiency and patient confidence.

For instance, in May 2023, Genea Biomedx Pty Ltd (a subsidiary of Genea Group) and AIVF Ltd. came together in a partnership to launch an integrated solution for personalized IVF care at a low cost. The integrated suite was built based on the Geri time-lapse incubator of Genea Biomedx and the EMA AI platform of AIVF.

According to reports, this technology improves embryo selection results by more than 25% when compared to traditional approaches by using deep-learning algorithms to evaluate embryo quality with previously unheard-of accuracy. Such advancements in technology not only demonstrate the revolutionary effects of digital health solutions in IVF but also highlight the market's dedication to further advancements in reproductive care. The US IVF market is expanding significantly because of the integration of these advancements, which improves treatment accessibility and efficacy.

Rising Infertility Rates and Changing Demographics Expedite the country's In-Vitro Fertilization Instruments Market Growth

Infertility rates in the United States are on the rise, primarily because of environmental causes, lifestyle-related health problems, and postponed childbirth. The need for assisted reproductive technologies, especially IVF, has increased as more people decide to have children later in life. Epidemiological statistics from 2023 suggested a considerable increase in infertility among women over 35, prompting both public awareness and aggressive fertility planning.

For example, Reproductive Health Partners, a well-known fertility centre in California, reported a 15% increase in IVF treatment cycles year over year in June 2023. This pattern is consistent with a larger demographic shift in which socioeconomic considerations and career-oriented lives cause people to put off family planning, which increases the need for medical intervention to conceive. As patients and healthcare professionals increasingly see IVF as a practical and occasionally required solution to age-related and lifestyle-induced fertility issues, the combination of rising infertility rates and changing societal standards has produced a favorable environment for market expansion.

Enhanced Regulatory and Insurance Support Fuel the US In-Vitro Fertilization Instruments Market Growth

Government policies and private insurance reforms in the United States have played a pivotal role in broadening access to IVF treatments. Increased regulatory support, along with mandates for better insurance coverage of fertility services, has lowered financial barriers, encouraging more couples to consider IVF.

In 2023, New York State enacted updated healthcare regulations that expanded insurance coverage for fertility treatments, including IVF, ensuring more patients could afford these procedures. Building on this momentum, in February 2024, a major private insurer, Blue Cross Blue Shield Association, announced a nationwide expansion of its fertility benefits program. This initiative significantly reduced out-of-pocket expenses for patients and spurred additional investments by clinics in advanced IVF technologies. Such regulatory and insurance advancements not only alleviate the financial burden on prospective parents but also stimulate market growth by increasing treatment accessibility. This supportive ecosystem is critical in driving demand and ensuring sustained growth in the competitive US IVF landscape.

Future Market Scenario (2025-2032F)

Many factors claim the growth of the United States in-vitro fertilization instruments market. Technological advancements give faster and more accurate results leading us to early diagnosis. Opportunity also lies in the increasing number of fertility concerns that the population is facing today. Promising initiatives of our government that provide healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone is testimonial.

For instance, in January 2024, IVIRMA Global SL, a global medical institution acquired Eugin Group's North American Operations, which included the Boston IVF fertility network and Toronto-based TRIO. The plan is to ensure the success of many patients while offering evidence-based fertility options.

Key Players Landscape and Outlook

Key players in the United States in-vitro fertilization industry leverage strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, Ovation Fertility and US Fertility merged in May 2023 to build a fertility platform that provides IVF and advanced fertility care in the United States.

Boston IVF and Cryoport, Inc. signed a three-year supply chain solutions agreement in April 2023 to facilitate the shipping of reproductive materials around the United States.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States In-vitro Fertilization Instruments Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Equipment
      • 4.2.1.1.1. Incubators
      • 4.2.1.1.2. Cryosystems
      • 4.2.1.1.3. Imaging Systems
      • 4.2.1.1.4. Ovum Aspiration Pumps
      • 4.2.1.1.5. Micromanipulators
      • 4.2.1.1.6. Sperm Separation Systems
      • 4.2.1.1.7. Others
    • 4.2.1.2. Reagents and Media
      • 4.2.1.2.1. Embryo Culture Media
      • 4.2.1.2.2. Cryopreservation Media
      • 4.2.1.2.3. Sperm Processing Media
      • 4.2.1.2.4. Others
    • 4.2.1.3. Software and Services
  • 4.2.2. By Procedure Type
    • 4.2.2.1. Fresh Donor IVF
    • 4.2.2.2. Fresh Non-Donor IVF
    • 4.2.2.3. Frozen Donor IVF
    • 4.2.2.4. Frozen Non-Donor IVF
    • 4.2.2.5. Natural Cycle IVF
    • 4.2.2.6. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Fertility Clinics
    • 4.2.3.2. Hospitals
    • 4.2.3.3. Research Institutes and Academic Centers
    • 4.2.3.4. Cryobanks
  • 4.2.4. By Region
    • 4.2.4.1. Northeast
    • 4.2.4.2. Midwest
    • 4.2.4.3. West
    • 4.2.4.4. South
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 4.3. Market Map Analysis, 2024
  • 4.3.1. By Product Type
  • 4.3.2. By Procedure Type
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Patent Landscape
• 12.2. Regulatory Approvals
• 12.3. Innovations/Emerging Technologies

13. Case Studies

14. Competitive Landscape

• 14.1. Competition Matrix of Top 5 Market Leaders
• 14.2. SWOT Analysis for Top 5 Players
• 14.3. Key Players Landscape for Top 10 Market Players
  • 14.3.1. Becton, Dickinson and Company
    • 14.3.1.1. Company Details
    • 14.3.1.2. Key Management Personnel
    • 14.3.1.3. Products and Services
    • 14.3.1.4. Financials (As Reported)
    • 14.3.1.5. Key Market Focus and Geographical Presence
    • 14.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 14.3.2. CooperSurgical, Inc.
  • 14.3.3. Thermo Fisher Scientific Inc.
  • 14.3.4. Irvine Scientific Inc.
  • 14.3.5. MilliporeSigma (Merck KGaA)
  • 14.3.6. Vitrolife Inc.
  • 14.3.7. Eppendorf North America, Inc.
  • 14.3.8. Leica Biosystems, Inc.
  • 14.3.9. Hamilton Company
  • 14.3.10. Origio USA, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States In-vitro Fertilization Market, By Value, In USD Billion, 2018-2032F
• Figure 2. United States In-vitro Fertilization Market Share (%), By Product Type, 2018-2032F
• Figure 3. United States In-vitro Fertilization Market Share (%), By Procedure Type, 2018-2032F
• Figure 4. United States In-vitro Fertilization Market Share (%), By End-user, 2018-2032F
• Figure 5. United States In-vitro Fertilization Market Share (%), By Region, 2018-2032F
• Figure 6. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 7. By Procedure Type Size Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 8. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 9. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024